IHT Wealth Management’s Lifecore Biomedical LFCR Stock Holding History

IHT Wealth Management’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-135	Closed	-$2K	–	944
2018 Q1	$2K	Hold	135	–	–	﹤0.01%	1507
2017 Q4	$2K	Hold	135	–	–	﹤0.01%	1494
2017 Q3	$2K	Hold	135	–	–	﹤0.01%	1220
2017 Q2	$16	Hold	135	–	–	0.01%	837
2017 Q1	$2K	Hold	135	–	–	﹤0.01%	1086
2016 Q4	$2K	Buy	+135	New	+$1.87K	﹤0.01%	1042

Other funds holding LFCR

NIMC

NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

TAM

THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

IHT Wealth Management's LFCR Position: Q2 2018 in Review

IHT Wealth Management sold out of Lifecore Biomedical (LFCR) in Q2 2018, closing a stake of 135 shares — an estimated $2K sold.

IHT Wealth Management first reported a position in LFCR in Q4 2016 and held it in 6 quarters. The position peaked at $2K in Q1 2018. 92 funds tracked by Wall St. Rank hold LFCR as of Q2 2018.

IHT Wealth Management reported no remaining Lifecore Biomedical position as of Q2 2018 after selling out during the quarter.
IHT Wealth Management sold 135 Lifecore Biomedical shares in Q2 2018, an estimated $2K.
IHT Wealth Management first reported a position in Lifecore Biomedical in Q4 2016 and held it in 6 quarters.
IHT Wealth Management's Lifecore Biomedical position peaked at $2K in Q1 2018.
92 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2018.

Based on IHT Wealth Management's 13F filing for Q2 2018, filed 13 Aug 2018.